Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 1985-1988

  Irani, J ^a   Ravery, V ^a   Pariente, J L ^a   Chartier Kastler, E ^a   Lechevallier, E ^a   Soulie M ^a   Chautard, D ^a   Coloby, P ^a   Fontaine, E ^a   Bladou, F ^a   Desgrandchamps, F ^a   Haillot, O ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Chemoprevention; Cyclooxygenase inhibitors; Finasteride; Prostatic neoplasms

Indexed keywords

ACETYLSALICYLIC ACID; FINASTERIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG USE; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE;

EID: 0036837486     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64277-2     Document Type: Article

References (19)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. CA Cancer J Clin, 48: 6, 1998
2. Shiff, S. J., Koutsos, M. I., Qiao, L. and Rigas, B.: Nonsteroidal antiinfiammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res, 222: 179, 1996
3. Liu, X. H., Kirschenbaum, A., Yao, S., Lee, R., Holland, J. F. and Levine, A. C.: Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol, 164: 820, 2000
4. Badawi, A. F.: The role of prostaglandin synthesis in prostate cancer. BJU Int, 85: 451, 2000
5. Homma, Y., Kaneko, M., Kondo, Y., Kawabe, K. and Kakizoe, T.: Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143. J Natl Cancer Inst, 89: 803, 1997
6. Ekman, P.: Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts. Eur Urol, 35: 362, 1999
7. Lim, J. T., Piazza, G. A., Han, E. K., Delohery, T. M., Li, H. and Finn, T. S.: Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol, 58: 1097, 1999
8. Norrish, A. E., Jackson, R. T. and McRae, C. U.: Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer, 77: 511, 1998
9. Bucher, C., Jordan, P., Nickeleit, V., Torhorst, J. and Mihatech, M. J.: Relative risk of malignant tumors in analgesic abusers. Effects of long-term intake of aspirin. Clin Nephrol, 51: 67, 1999
10. Langman, M. J., Cheng, K. K., Gilman, E. A. and Lancashine, R. J.: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ, 320: 1642, 2000
11. Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H. O., Hacker, D. G. et al: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst, 85: 307, 1993
12. Ross, R. K., Bernstein, L., Lobo, R. A., Shimizu, H., Stanczyk, F. Z., Pike, M. C. et al: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet, 339: 887, 1992
13. Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D. et al: The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med, 327: 1185, 1992
14. Guess, H. A., Friedman, G. D., Sadler, M. C., Stanczyk, F. Z., Vogelman, J. H., Imperato-McGinley, J. et al: 5 Alpha-reductase activity and prostate cancer: a case-control study using stored sera. Cancer Epidemiol Biomarkers Prev, 6: 21, 1997
15. Coltman, C. A., Jr., Thompson, I. M., Jr. and Feigl, P.: Prostate Cancer Prevention Trial (PCPT) update. Eur Urol, 35: 544, 1999
16. Putnam, S. D., Cerhan, J. R., Parker, A. S., Bianchi, G. D., Wallace, R. B., Cantor, K. P. et al: Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol, 10: 361, 2000
17. Nilsen, T. I. and Vatten, L. J.: Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men. Cancer Causes Control, 10: 269, 1999
18. Gronberg, H., Damber, L. and Damber, J. E.: Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol, 155: 969, 1996
19. Keller-Byrne, J. E., Khuder, S. A. and Schaub, E. A.: Meta-analyses of prostate cancer and farming. Am J Ind Med, 31: 580, 1997